BPC-157 + TB-500 (5mg + 5mg)
Description & mechanism
This preparation combines BPC-157 (5 mg), a gastric-derived synthetic pentadecapeptide, with TB-500 (5 mg), a thymosin-beta-4-derived fragment. It is used in research to investigate the combined effects of the two peptides on angiogenesis and cell migration in cell-culture models.
Applications in research
- Combined angiogenesis and cell-migration assays in vitro
- Fibroblast and endothelial co-culture signalling studies
- Comparative single-agent versus mixture research
Specifications
Handling, reconstitution & storage
Reconstitute the lyophilized solid in sterile water or bacteriostatic diluent to the desired working concentration; mix by gentle inversion and avoid vigorous agitation or repeated freeze-thaw. Sterile-filter (0.22 µm) if aseptic use is required, aliquot into single-use volumes, and store reconstituted material frozen at -20 °C.
Precautions & notes
For in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden. Handle as a bioactive substance using appropriate PPE and consult the safety data sheet. Note: these compounds are listed by the World Anti-Doping Agency (S0/S2); this designation concerns competitive sport and is unrelated to research use.
This product is furnished for in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden.